Ki-Hoon Park, Hwajin Lee, Ji Hyun Lee, Dong Keon Yon, Young-Il Choi, Hyung-Joo Chung, Junyang Jung, Na Young Jeong
{"title":"通过转录组学数据整合发现酒精性和非酒精性肝硬化的独特和共同分子机制","authors":"Ki-Hoon Park, Hwajin Lee, Ji Hyun Lee, Dong Keon Yon, Young-Il Choi, Hyung-Joo Chung, Junyang Jung, Na Young Jeong","doi":"10.1089/omi.2024.0168","DOIUrl":null,"url":null,"abstract":"<p><p>Liver cirrhosis is a severe chronic disease that results from various etiological factors and leads to substantial morbidity and mortality. Alcoholic cirrhosis (AC) and non-AC (NAC) arise from prolonged and excessive consumption of alcohol and metabolic syndromes, respectively. Precise molecular mechanisms of AC and NAC are yet to be comprehensively understood for diagnostics and therapeutic advances to materialize. This study reports novel findings to this end by utilizing high-throughput RNA sequencing and microarray data from the Gene Expression Omnibus (GEO). We performed a meta-analysis of transcriptomics data to identify the differentially expressed genes specific to AC and NAC. Functional enrichment and protein-protein interaction network analyses uncovered novel hub genes and transcription factors (TFs) critical to AC and NAC. We found that AC is primarily driven by metabolic dysregulation and oxidative stress, with key TFs such as RELA, NFKB1, and STAT3. NAC was characterized by fibrosis and tissue remodeling associated with metabolic dysfunction, with TFs including USF1, MYCN, and HIF1A. Key hub genes such as <i>ESR1</i>, <i>JUN</i>, <i>FOS</i>, and <i>PKM</i> in AC, and <i>CD8A</i>, <i>MAPK3</i>, <i>CCND1</i>, and <i>CXCR4</i> in NAC were identified, along with their associated TFs, pointing to potential therapeutic targets. Our results underscore the unique and shared molecular mechanisms that underlie AC and NAC and inform the efforts toward precision medicine and improved patient outcomes in liver cirrhosis.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unique and Shared Molecular Mechanisms of Alcoholic and Non-Alcoholic Liver Cirrhosis Identified Through Transcriptomics Data Integration.\",\"authors\":\"Ki-Hoon Park, Hwajin Lee, Ji Hyun Lee, Dong Keon Yon, Young-Il Choi, Hyung-Joo Chung, Junyang Jung, Na Young Jeong\",\"doi\":\"10.1089/omi.2024.0168\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Liver cirrhosis is a severe chronic disease that results from various etiological factors and leads to substantial morbidity and mortality. Alcoholic cirrhosis (AC) and non-AC (NAC) arise from prolonged and excessive consumption of alcohol and metabolic syndromes, respectively. Precise molecular mechanisms of AC and NAC are yet to be comprehensively understood for diagnostics and therapeutic advances to materialize. This study reports novel findings to this end by utilizing high-throughput RNA sequencing and microarray data from the Gene Expression Omnibus (GEO). We performed a meta-analysis of transcriptomics data to identify the differentially expressed genes specific to AC and NAC. Functional enrichment and protein-protein interaction network analyses uncovered novel hub genes and transcription factors (TFs) critical to AC and NAC. We found that AC is primarily driven by metabolic dysregulation and oxidative stress, with key TFs such as RELA, NFKB1, and STAT3. NAC was characterized by fibrosis and tissue remodeling associated with metabolic dysfunction, with TFs including USF1, MYCN, and HIF1A. Key hub genes such as <i>ESR1</i>, <i>JUN</i>, <i>FOS</i>, and <i>PKM</i> in AC, and <i>CD8A</i>, <i>MAPK3</i>, <i>CCND1</i>, and <i>CXCR4</i> in NAC were identified, along with their associated TFs, pointing to potential therapeutic targets. Our results underscore the unique and shared molecular mechanisms that underlie AC and NAC and inform the efforts toward precision medicine and improved patient outcomes in liver cirrhosis.</p>\",\"PeriodicalId\":2,\"journal\":{\"name\":\"ACS Applied Bio Materials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":4.6000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ACS Applied Bio Materials\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://doi.org/10.1089/omi.2024.0168\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/10/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"MATERIALS SCIENCE, BIOMATERIALS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1089/omi.2024.0168","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/17 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
摘要
肝硬化是一种严重的慢性疾病,由多种病因引起,导致大量的发病和死亡。酒精性肝硬化(AC)和非酒精性肝硬化(NAC)分别源于长期过量饮酒和代谢综合征。酒精性肝硬化和非酒精性肝硬化的精确分子机制尚待全面了解,以实现诊断和治疗的进步。本研究利用基因表达总库(GEO)中的高通量 RNA 测序和微阵列数据,报告了这方面的新发现。我们对转录组学数据进行了荟萃分析,以确定 AC 和 NAC 的特异性差异表达基因。功能富集和蛋白-蛋白相互作用网络分析发现了对 AC 和 NAC 至关重要的新型枢纽基因和转录因子 (TF)。我们发现 AC 主要由代谢失调和氧化应激驱动,关键转录因子包括 RELA、NFKB1 和 STAT3。NAC的特点是纤维化和组织重塑,与代谢功能障碍有关,TF包括USF1、MYCN和HIF1A。我们发现了 AC 中的 ESR1、JUN、FOS 和 PKM 等关键枢纽基因,以及 NAC 中的 CD8A、MAPK3、CCND1 和 CXCR4 等关键枢纽基因及其相关的 TFs,从而发现了潜在的治疗靶点。我们的研究结果强调了 AC 和 NAC 独特而又共同的分子机制,为实现精准医疗和改善肝硬化患者预后提供了信息。
Unique and Shared Molecular Mechanisms of Alcoholic and Non-Alcoholic Liver Cirrhosis Identified Through Transcriptomics Data Integration.
Liver cirrhosis is a severe chronic disease that results from various etiological factors and leads to substantial morbidity and mortality. Alcoholic cirrhosis (AC) and non-AC (NAC) arise from prolonged and excessive consumption of alcohol and metabolic syndromes, respectively. Precise molecular mechanisms of AC and NAC are yet to be comprehensively understood for diagnostics and therapeutic advances to materialize. This study reports novel findings to this end by utilizing high-throughput RNA sequencing and microarray data from the Gene Expression Omnibus (GEO). We performed a meta-analysis of transcriptomics data to identify the differentially expressed genes specific to AC and NAC. Functional enrichment and protein-protein interaction network analyses uncovered novel hub genes and transcription factors (TFs) critical to AC and NAC. We found that AC is primarily driven by metabolic dysregulation and oxidative stress, with key TFs such as RELA, NFKB1, and STAT3. NAC was characterized by fibrosis and tissue remodeling associated with metabolic dysfunction, with TFs including USF1, MYCN, and HIF1A. Key hub genes such as ESR1, JUN, FOS, and PKM in AC, and CD8A, MAPK3, CCND1, and CXCR4 in NAC were identified, along with their associated TFs, pointing to potential therapeutic targets. Our results underscore the unique and shared molecular mechanisms that underlie AC and NAC and inform the efforts toward precision medicine and improved patient outcomes in liver cirrhosis.